Levophenacylmorphan
 | |
| Systematic (IUPAC) name | |
|---|---|
| (−)-3-Hydroxy-N-phenacylmorphinan | |
| Clinical data | |
| |
| Identifiers | |
10061-32-2  | |
| None | |
| PubChem | CID 5362482 |
| ChemSpider |
16736786  |
| UNII |
7Q24AL2BR2 |
| Synonyms | Levophenacylmorphan |
| Chemical data | |
| Formula | C24H27NO2 |
| 361.48 g/mol | |
|
SMILES
| |
| |
| (what is this?) (verify) | |
Levophenacylmorphan is a morphinan derivative that acts as an opioid agonist. It has potent analgesic effects and is around 10x more potent than morphine.[1] Adverse effects associated with its use are those of the opioids as a whole, including pruritus, nausea, respiratory depression, euphoria and development of tolerance and dependence to its effects.[2]
References
- ↑ MAY, E.L. & EDDY, N.B., A New Potent Synthetic Analgesic, J. Org. Chem., 24 : 294, 1959.
- ↑ Fraser HF, Isbell H. Human pharmacology and addiction liabilities of phenazocine and levophenacylmorphan. UN Bulletin on Narcotics. 1960 Issue 2